1. Hematology:

• Complete Blood Count (CBC)
• Ensure the CBC includes the parameters required for estimating
• biological age: WBC, lymphocyte %, MCV, and RDW.

2. Blood glucose and glucose metabolism:

• Fasting Blood Sugar
• HbA1c

3. Blood lipids and cardiometabolic risk:

• Total Cholesterol
• Triglyceride
• HDL-Cholesterol
• LDL-Cholesterol

4. Uric acid and metabolism:

• Uric Acid

5. Renal function and electrolyte balance:

• Creatinine/eGFR
• Urea
• Serum electrolytes: Sodium, Potassium, Chloride
• Calcium/Ca++

6. Liver function, serum proteins, and tissue metabolism:

• SGOT/AST
• SGPT/ALT
• Gamma GT/GGT
• Alkaline Phosphatase/ALP
• Albumin

7. Thyroid:

• TSH
• Free T3
• Free T4

8. Viral hepatitis:

• HBsAg
• HBsAb/Anti-HBs
• Anti-HCV
• Consider adding total anti-HBc if the goal is a comprehensive classification of hepatitis B status.

9. Systemic inflammation:

• CRP
• Consider hs-CRP if the goal is to assess low-grade inflammation or cardiometabolic risk.

• Supports baseline health assessment prior to cell-based therapy: provides data on hematology, liver and kidney function, electrolytes, blood glucose, lipids, thyroid function, viral hepatitis status, and inflammation levels for clinical evaluation.
• Assists in estimating biological age using blood biomarkers: Albumin, Creatinine, Glucose, CRP, ALP, and CBC parameters (such as WBC, lymphocyte percentage, MCV, and RDW) can be utilized in algorithms to estimate biological age (e.g., phenotypic age).
• Assesses baseline inflammation: CRP helps indicate acute or systemic inflammation; elevated CRP levels require investigation into the underlying cause before interpreting biological age or proceeding with restorative therapy.
• Evaluates liver function and protein reserves: AST, ALT, GGT, ALP, and Albumin assist clinicians in assessing liver and biliary health, nutritional status, protein synthesis, and the body’s biological responsiveness.
  Evaluates kidney function and electrolyte balance: Creatinine/eGFR, Urea, Sodium, Potassium, Chloride, and Calcium help assess safety prior to infusion/injection therapies or intensive care procedures.

• Assessment of glucose and lipid metabolism: Fasting Blood Sugar, HbA1c, and lipid profile help identify risks associated with pre-diabetes, diabetes, dyslipidemia, and cardiometabolic issues.
• Thyroid assessment: TSH, FT3, and FT4 aid in detecting thyroid disorders that may impact fatigue, weight, heart rate, sleep, metabolism, and recovery.
  Initial screening for Hepatitis B/C: helps identify the risk of viral liver disease or Hepatitis B immunity status prior to intensive health programs.
• Pre- and post-treatment monitoring: results can serve as baseline data for periodic comparison following interventions; however, interpretation must account for the timing of sample collection, inflammation, acute illness, current medications, and lifestyle changes.

• Clients planning to undergo cell-based therapies, intensive recovery regimens, IV therapy, or personalized wellness programs.
• Clients wishing to assess baseline metrics to help estimate biological age using blood biomarkers.
• Individuals experiencing persistent fatigue, slow recovery, chronic stress, sleep disturbances, weight fluctuations, or unexplained physical decline.
• Individuals with metabolic risk factors such as being overweight, abdominal obesity, a sedentary lifestyle, dyslipidemia, hyperglycemia, hypertension, gout, or a family history of metabolic disease.

• Individuals at risk of alcohol-related liver disease, fatty liver, or liver issues due to long-term medication use, abnormal liver enzymes, or unknown Hepatitis B/C status.
• Individuals exhibiting symptoms suggestive of thyroid disorders, such as palpitations, hand tremors, weight loss or gain, cold intolerance, constipation, hair loss, fatigue, or menstrual irregularities.
• Clients requiring periodic monitoring before and after an intensive health care program to assess biomarker trends over time.

• You should fast for approximately 8–12 hours before the blood draw if tests for fasting blood glucose and triglycerides are included; plain water is permitted.
• If possible, avoid alcohol, high-fat meals, and strenuous physical activity for 24 hours prior to the test.
• Do not provide a sample if you have a fever, an acute infection, an injury, recent surgery, severe vomiting, or acute inflammation—particularly if the primary goal is determining biological age—as CRP levels and certain blood markers may be affected.
• Do not discontinue any medications you are currently taking without consulting your doctor.

• Inform your doctor about any medications, thyroid hormones, antithyroid drugs, statins, diabetes medications, blood pressure medications, anti-inflammatories, corticosteroids, anticoagulants, vitamins, biotin, liver supplements, or recent infusion/injection treatments you are using.
• If you are taking biotin, you must inform your doctor, as biotin can interfere with certain immunoassay tests, particularly those for thyroid function and hormones.
• If the goal is to monitor results before and after a treatment course, blood samples should ideally be collected at the same time of day, under the same fasting conditions, and at the same laboratory.

• Biological age: An estimate based on algorithms and blood biomarkers, not a diagnostic conclusion. Results may fluctuate temporarily due to inflammation, infection, sleep deprivation, severe stress, dehydration, medication use, or recent strenuous exercise.
• Elevated CRP: The underlying cause of inflammation, infection, or tissue injury must be identified before drawing conclusions regarding biological age or treatment efficacy.
• Low albumin: May be associated with nutritional status, chronic inflammation, liver disease, kidney disease, protein loss, or systemic conditions requiring further evaluation.
• Elevated ALP: May be linked to hepatobiliary or bone disorders, or other causes; correlation with GGT, bilirubin, calcium, vitamin D, PTH, or imaging studies may be required.
• Elevated liver enzymes: Requires assessment for alcohol consumption, medication use, fatty liver, viral hepatitis, hepatobiliary disease, or muscle disorders.

• HBsAg-positive: requires hepatobiliary specialist assessment and testing for HBV DNA, HBeAg/anti-HBe, liver enzymes, and liver fibrosis staging, as appropriate.
• HBsAb low/negative: hepatitis B vaccination may be indicated if immunity is absent and there are no contraindications.
• Anti-HCV positive: requires HCV RNA testing to determine the presence of active HCV infection.
• Abnormal TSH/FT3/FT4: may require thyroid antibody testing, thyroid ultrasound, or endocrinology consultation.
• Reduced eGFR or abnormal electrolytes: requires assessment of renal function, current medications, hydration status, and risk factors prior to infusion or injection.